---
title: "India Data Analysis"
author: W. Evan Johnson
date: "`r Sys.Date()`"
output:
  html_document:
    code_folding: show
    toc: true
    toc_float: true
    theme: "flatly"
editor_options: 
  chunk_output_type: console
---

## Introduction
Now its time to practice what we have learned in class and learn even more! For this homework project you will do an RNA-seq analysis of a [TB/Malnutrition dataset](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1011166/full). 

<!-- 
## Batch correction
```{r, eval=F, include=F}
library(SummarizedExperiment)
library(sva)
library(TBSignatureProfiler)

indata <- readRDS("~/Desktop/indata.rds")

batch <- indata$batch
covs <- model.matrix(~colData(indata)$Tb_status + colData(indata)$bmi_cat2)

combat_counts <- ComBat_seq(as.matrix(assay(indata, "counts")), 
      batch = batch, covar_mod = covs)
assay(indata, "combat") <- combat_counts

## Make log counts, counts per million (cpm), logcpm
indata <- mkAssay(indata, input_name = "combat",log = TRUE, 
                     counts_to_CPM = TRUE)
assays(indata)
saveRDS(indata, "~/Desktop/combat_indata.rds")
```
-->

Begin by reading the `indata.rds` file: 

```{r}
suppressMessages({library(SummarizedExperiment)})
indata <- readRDS("combat_indata.rds")
assays(indata)
```

Please use the batch corrected `combat` (counts) and `log_combat_cpm` (log cpm) assays for your analyses. 

## Analysis steps: 


1.\  Preprocess these data by removing any genes with zero expression for all samples, and by generating a log counts per million assay. Make a two dimensional table for TB status and malnutrition status. 

```{r, eval=F, include=F}
# Remove genes with all zero counts
keep <- rowSums(assay(indata,"combat")) > 0
sum(!keep) ## answer!
indata <- indata[keep, ]

# Table 
table(colData(indata)[,2:3])
```
  
2.\  Apply PCA and UMAP to your data and generate dimension reduction plots for the results. Use different colors for the TB and LTBI samples (`Tb_status`). Use different plotting symbols for malnourishment (`bmi_cat2`). Note that you should be using the log CPM values for this analysis. 

```{r, eval=F, include=F }  
library(tidyverse)
library(umap)

pca_out <- prcomp(t(assay(se,"logCPM")))
pca_plot <- data.frame(pca_out$x, Disease=se$disease_status)
pca_plot %>% ggplot(aes(x=PC1, y=PC2, color=Disease)) + geom_point(size=1.5)

set.seed(1)
umap_out <- umap(t(assay(se,"logCPM")))
umap_plot <- data.frame(umap_out$layout, Disease=se$disease_status)
umap_plot %>% ggplot(aes(x=X1, y=X2, color=Disease)) + geom_point(size=1.5)
```

3.\  Use `DESeq2` to do a differential expression analysis (on the counts) comparing the TB to the LTBI samples adjusting for BMI status. What are the most differentially expressed genes? 
  

```{r, eval=F, include=F }  
library(DESeq2)
dds <- DESeqDataSetFromMatrix(countData = assay(se,"counts"), colData = colData(se), design = ~ disease_status)
dds <- DESeq(dds)
res <- results(dds, contrast = c("disease_status", "TB-HIV", "HIV"))
top_genes_deseq <- res[head(order(res$pvalue), 50),]
```

4.\ Make a heatmap plot of the `DESeq2` results (top 50). Add a colorbar for disease and BMI status. 
 
```{r, eval=F, include=F }  
library(ComplexHeatmap)
mat = as.matrix(assay(se,"counts"))[order(results(dds)[,6])[1:50],] 
mat = t(scale(t(mat))) ## scale gene expression
df=data.frame(Disease=colData(se)$disease_status) 
ha = HeatmapAnnotation(df = df, col = list(Disease=c("TB-HIV"="Red", "HIV"="Blue")))
Heatmap(mat,show_row_names=F, show_column_names = F, top_annotation = ha)
```
  
5.\ Conduct a pathway analysis of the top 50 DESeq2 genes using enrichR (through R or online). Use the "Reactome\_Pathways\_2024" database. What is are the top scoring pathways?
 

```{r, eval=F, include=F }  
library(enrichR)
setEnrichrSite("Enrichr")
db_list <- listEnrichrDbs()
genes <- rownames(limma_res)
results <- enrichr(genes, databases = c("Reactome_Pathways_2024"))
head(results[[1]])
```
  

6.\ Using the well-nourished samples as your training set, develop Elastic Net (logistic regression), SVM, and Random Forest predictors for TB status. Compare the cross-validation overall accuracy for these three methods. 

7.\ Apply your biomarkers to the malnourished samples (as a validation set). How do your biomarkers perform? Should we develop biomarkers for the malnourished samples independently? 

8.\ (Extra) Develop Elastic Net (logistic regression), SVM, and Random Forest predictors for TB status in the malnourished samples. How does the cross vaidation accuracy compare with the accuracies in 6 and 7? 
